Benchmark study of benzamide derivatives and four novel theoretically designed (L1, L2, L3, and L4) ligands and evaluation of their biological properties by DFT approaches.


Journal

Journal of molecular modeling
ISSN: 0948-5023
Titre abrégé: J Mol Model
Pays: Germany
ID NLM: 9806569

Informations de publication

Date de publication:
13 Jul 2019
Historique:
received: 03 02 2019
accepted: 02 07 2019
entrez: 15 7 2019
pubmed: 16 7 2019
medline: 21 12 2019
Statut: epublish

Résumé

Four novel ligands, namely N-benzhydryl benzamide, N, N-diphenethyl benzamide, N, N-dihexyl benzamide, and N, N-dioctyl benzamide (L1, L2, L3, and L4, respectively), based on the benzamide unit were designed and computed for their different properties, such as absorption spectrum, dipole moment, theoretically expected biological properties, and frontier molecular orbitals, by evaluating the HOMO/LUMO energy orbitals strength with DFT approaches and comparing these properties with the R benzamide properties available in literature. All molecules have a suitable frontier molecular orbital diagram and L1 exhibits maximum absorption at 246.8 nm due to the strong electron donating effect of the diphenylmethane ligand group. Moreover, strongly extended conjugated groups caused a redshift in absorption spectra. Newly designed molecules may show strong biological activities against cancer, bacterial diseases, and harmful fungal disorders. Graphical abstract Orbital energy, electron density and frontier molecular orbitals view of four designed novel benzamide derivates.

Identifiants

pubmed: 31302811
doi: 10.1007/s00894-019-4115-3
pii: 10.1007/s00894-019-4115-3
doi:

Substances chimiques

Benzamides 0
Ligands 0
benzamide 6X80438640

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

223

Références

Ann Intern Med. 1995 Jul 15;123(2):132-42
pubmed: 7778826
Eur J Med Chem. 2017 May 26;132:42-62
pubmed: 28340413
ACS Catal. 2019 Jan 4;9(1):205-210
pubmed: 31105988
J Comput Chem. 2010 Dec;31(16):2874-82
pubmed: 20928850
Eur J Med Chem. 2012 Oct;56:400-8
pubmed: 22926227
Urology. 2003 Sep;62(3):537-41
pubmed: 12946763
Angew Chem Int Ed Engl. 2011 Nov 11;50(46):10800-26
pubmed: 22038946
Chem Rev. 2010 Mar 10;110(3):1611-41
pubmed: 19928825
Org Lett. 2004 Jan 8;6(1):27-30
pubmed: 14703342
Cochrane Database Syst Rev. 2000;(2):CD000067
pubmed: 10796482
Phys Chem Chem Phys. 2008 Nov 28;10(44):6615-20
pubmed: 18989472
Arch Intern Med. 1966 Dec;118(6):528-33
pubmed: 5925440
Arch Pharm (Weinheim). 2000 Nov;333(11):365-72
pubmed: 11129978
Melanoma Res. 2005 Oct;15(5):383-91
pubmed: 16179865
Org Biomol Chem. 2018 May 9;16(18):3419-3427
pubmed: 29675524

Auteurs

Department of Chemistry, University of Agriculture Faisalabad, Faisalabad, 38040, Pakistan.

Usman Ali (U)

Department of Chemistry, University of Agriculture Faisalabad, Faisalabad, 38040, Pakistan. usmanqureshi320@gmail.com.

Muhammad Ans (M)

Department of Chemistry, University of Agriculture Faisalabad, Faisalabad, 38040, Pakistan.

Javed Iqbal (J)

Department of Chemistry, University of Agriculture Faisalabad, Faisalabad, 38040, Pakistan. javedkhattak79@gmail.com.
Punjab Bio-energy Institute, University of Agriculture, Faisalabad, 38040, Pakistan. javedkhattak79@gmail.com.

Muhammad Adnan Iqbal (MA)

Department of Chemistry, University of Agriculture Faisalabad, Faisalabad, 38040, Pakistan. adnan.iqbal@uaf.edu.pk.
Organometallic and Coordination Chemistry Laboratory, Department of Chemistry, University of Agriculture, Faisalabad, 38040, Pakistan. adnan.iqbal@uaf.edu.pk.

Muhammad Shoaib (M)

Department of Chemistry, University of Agriculture Faisalabad, Faisalabad, 38040, Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH